source
- AstraZeneca and Bristol Myers Squibb reportedly in talks on a mega mergerAstraZeneca is said to be discussing a possible merger with Bristol Myers Squibb, according to a Financial Times report published on Sunday. The combination would rank among the largest consolidat…
- Alnylam’s stock continues to fall as weekly roundup highlights Q2 earnings across biopharmaThe August 1 edition of Endpoints Weekly opens with a look at the latest biopharma earnings season. Alnylam Therapeutics is highlighted for a continued decline in its share price, reflecting ongoi…